Clinical trials

  • TALAZOPARIB for Malignant pleural mesothelioma | Malignant peritoneal mesothelioma
  • BI 765063 for Non-small cell lung cancer|Melanoma|Head and neck squamous cell carcinoma
  • Obinutuzumab for Cryoglobulinemia vasculitis | Mixed cryoglobulinemia
  • multi-peptide(s) and XS15 (TLR1/2 ligand) for Acute myeloid leukemia
  • IZORLISIB MESILATE for Triple-negative breast cancer | HR-positive HER2-negative breast cancer (metaplastic)
  • Pembrolizumab for Malignant pleural mesothelioma | Epithelioid pleural mesothelioma | Biphasic pleural mesothelioma
  • CARBOPLATIN for Nephroblastoma (Wilms tumour) | Metastatic (Stage IV) childhood nephroblastoma
  • VENETOCLAX for Acute myeloid leukemia
  • AL8326 for Small cell lung cancer
  • Rivaroxaban for Coronary artery disease | Atrial fibrillation | Percutaneous coronary intervention
  • VEDOLIZUMAB for Crohn's disease
  • DIACEREIN for Generalized epidermolysis bullosa simplex